Michel J B
Unité 36 de l'INSERM, Paris.
Arch Mal Coeur Vaiss. 1991 Dec;84 Spec No 4:51-61.
Experimental myocardial infarction is a model of cardiac overload due to amputation of part of the cardiac muscle. The development of cardiac failure depends on the size of the infarct and the time factor. This model of overload is associated with changes of the phenotype of the remaining healthy muscle and with peripheral vascular modifications partially dependent of the activation of pressor and/or deactivation of dilator systems. These changes are proportional to the size of the infarction at a given time after induction of the model. The degree of right ventricular hypertrophy and the decrease in blood pressure reflect the severity of infarction and the deterioration of the remaining myocardial function, affecting the haemodynamics both before and after the left ventricle. The increases in the 1/3 forms of isomyosins, the amount of subendocardial collagen, the biosynthesis, stocking and secretion of ANF are related to the infarct size and degree of overload. Similarly, the concentration of cyclic GMP is proportional to the infarct size. These parameters reflect ventricular overload, the increase of stress and energy deprivation of the remaining healthy muscle. The activation of peripheral pressor systems is also dependent on the infarct size reflects the effect of cardiac pump dysfunction on the kidney, liver, brain and endothelium. Large infarcts are associated with increased circulating renin and renal concentrations, with a decrease in angiotensinogen levels related to its consumption by the renin and to reduced hepatic synthesis and also with increased secretion and biosynthesis of vasopressin by the hypothalamus. In this model, Perindopril is beneficial by decreasing the cardiac load. It reduces the blood pressure, causes regression of bi-auricular and right ventricular hypertrophy. Changes in myosin isoenzyme configuration regress and subendocardial fibrosis and ANF concentrations are normalised. The effects of ACE inhibitors in this context, though very beneficial, are limited by the impossibility of normalising cardiac load and stress when the initial amputation of cardiac contractile mass exceeds 40%.
实验性心肌梗死是由于部分心肌被切除而导致心脏负荷过重的一种模型。心力衰竭的发展取决于梗死面积大小和时间因素。这种负荷过重模型与剩余健康心肌的表型变化以及部分依赖于升压系统激活和/或扩张系统失活的外周血管改变有关。在模型诱导后的特定时间,这些变化与梗死面积成正比。右心室肥厚程度和血压下降反映了梗死的严重程度以及剩余心肌功能的恶化,影响左心室前后的血液动力学。1/3型异肌球蛋白形式的增加、心内膜下胶原量、心房钠尿肽的生物合成、储存和分泌与梗死面积和负荷过重程度相关。同样,环磷酸鸟苷的浓度与梗死面积成正比。这些参数反映了心室负荷过重、应激增加以及剩余健康心肌的能量剥夺。外周升压系统的激活也取决于梗死面积,反映了心脏泵功能障碍对肾脏、肝脏、大脑和内皮的影响。大面积梗死与循环肾素和肾脏浓度增加、与肾素消耗及肝脏合成减少相关的血管紧张素原水平降低以及下丘脑抗利尿激素分泌和生物合成增加有关。在这个模型中,培哚普利通过降低心脏负荷而有益。它降低血压,使双心房和右心室肥厚消退。肌球蛋白同工酶构型的变化消退,心内膜下纤维化和心房钠尿肽浓度恢复正常。在这种情况下,血管紧张素转换酶抑制剂的作用虽然非常有益,但当心脏收缩物质的初始切除超过40%时,由于无法使心脏负荷和应激恢复正常而受到限制。